Nuvilab Secures Series A Bridge Funding to Scale AI Nutrition Analytics

NAVER D2SF, the corporate venture capital arm of NAVER, has announced a follow-on investment in Nuvilab, an AI-powered nutrition analytics and healthcare startup. Participating in Nuvilab’s Series A bridge round, NAVER D2SF cited the company’s high growth potential in the North American clinical market and its successful transition from B2G validation to global healthcare scaling.

Founded in 2021, Nuvilab has developed a proprietary nutrition management solution that utilises real-time image-based scanning to analyse food type, intake, and nutritional density. The reinvestment follows a period of rapid international expansion, with the startup securing over 1,000 global clients by the end of 2025.

Technical Benchmarks and Data Collection

The core of Nuvilab’s value proposition lies in its multimodal AI model, which has been trained on a dataset exceeding 100 million food data points. This extensive library allows the technology to deliver 98% analytical accuracy within a 0.3-second processing window.

Unlike traditional manual logging apps, Nuvilab utilises a "passive collection" model:

Hardware Integration: Scanners are installed in existing environments such as hospitals, schools, and daycare centres.

Frictionless UX: Data is captured automatically during the meal service process, requiring no manual input from the user or caregiver.

Retention Metrics: This seamless approach has resulted in a 95% user retention rate, significantly outperforming the healthcare industry average for digital nutrition tools.

North American Healthcare

While Nuvilab established its initial footprint in Korea’s B2B and B2G sectors, its current strategic focus is the North American healthcare market. The company has moved beyond simple calorie tracking to address critical operational inefficiencies in clinical food service.

A significant milestone in this expansion is an exclusive partnership with one of the world’s largest catering conglomerates. This deal focuses on supplying Nuvilab’s AI scanners to hospitals across the United States to automate food safety and patient meal verification.

Food Safety and Error Reduction

Nuvilab has demonstrated tangible ROI in hospital environments by automating the verification process that matches patient-specific meal tickets with the actual food served. According to Proof of Concept (PoC) results:

Error Reduction: Automated AI verification reduced meal-matching errors by 49%.

Time Efficiency: The system shortened food preparation and verification times by 23% compared to manual legacy processes.

Clinical Accuracy: Real-time dietary intake analytics provide clinicians with precise data on patient consumption, which is critical for recovery monitoring and malnutrition prevention.

Future Roadmap and Data Structuring

Logan Kim, CEO of Nuvilab, noted that while dietary habits are a fundamental pillar of health, the data have historically remained unstructured and underutilised. Nuvilab’s objective is to categorise and structure this data through AI to create a new standard for precision nutrition.

Moving forward into 2026, Nuvilab plans to expand its integration capabilities to include:

Insurer Partnerships: Linking dietary data to health outcomes for premium adjustments and wellness incentives.
Pharmaceutical Integration: Monitoring nutritional status in relation to drug efficacy and clinical trials.
Chronic Disease Management: Developing specialised modules for diabetic and renal care.

Market Outlook

For B2B stakeholders, Nuvilab’s success represents the "industrialisation" of nutrition data. As hospitals face increasing pressure to improve patient outcomes while reducing labour costs, the automation of meal logistics via computer vision provides a clear path to operational efficiency. NAVER D2SF’s continued backing signals strong confidence in Nuvilab's ability to define a new global category in the intersection of AI, food service, and clinical healthcare.